Exact Mass: 498.33787700000005
Exact Mass Matches: 498.33787700000005
Found 128 metabolites which its exact mass value is equals to given mass value 498.33787700000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
PoricoicacidA
Poricoic acid A is a tricyclic triterpenoid isolated from Poria cocos. It has a role as a fungal metabolite. It is a tricyclic triterpenoid, a dicarboxylic acid and a secondary alcohol. Poricoic acid A is a natural product found in Phellodendron amurense and Wolfiporia cocos with data available. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2]. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2].
Poricoic
Poricoic acid A is a tricyclic triterpenoid isolated from Poria cocos. It has a role as a fungal metabolite. It is a tricyclic triterpenoid, a dicarboxylic acid and a secondary alcohol. Poricoic acid A is a natural product found in Phellodendron amurense and Wolfiporia cocos with data available. A tricyclic triterpenoid isolated from Poria cocos. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2]. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2].
poricoic acid F
Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2]. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2].
15-Hydroxy-14,15-dihydro-isoborreverin|7,7,9-trimethyl-11-(2-methylamino-ethyl)-6-[3-(2-methylamino-ethyl)-1H-indol-2-yl]-6a,7,8,9,10,10a-hexahydro-6H-isoindolo[2,1-a]indol-9-ol|Hydroxy-15-dihydro-14,15-isoborreverin
(3beta,4alpha)-4-hydroxy-3,23-(isopropylidenedioxy)-24,30-dinoroleana-12,20(29)-dien-28-oic acid
2-(1-Hydroxy-1,5-dimethyl-4-hexenyl)-2,3-dihydro-5-methyl-7-(2-methylpropanoyl)-5,7-diprenylbenzofuran-4,6(5H,7H)-dione
10-[3-(2-methylamino-ethyl)-indol-2-yl]-1,1,3,13-tetramethyl-2,3,4,4a,10,10a-hexahydro-1H,5H-4b,9b-[1]azapropano-indeno[1,2-b]indol-3-ol|15-Hydroxy-14,15-dihydroborrererin|Hydroxy-15 dihydro-14,15 borreverin
(20xi)-16alpha,25-dihydroxy-3-oxo-24-methyllanosta-7,9(11),24(241)-trien-21-oic acid|16alpha,25-dihydroxydehydroeburiconic acid
2-(1-Hydroxy-1,5-dimethyl-4-hexenyl)-2,3-dihydro-7-methyl-5-(2-methylpropanoyl)-5,7-diprenylbenzofuran-4,6(5H,7H)-dione
3beta,6alpha-diacetoxy-5alpha-cholesta-9(11),20(22)-dien-23-one
1,2-dehydro-2,3-seco-2,24-epoxy-D:A-friedooleane-29-oic acid methyl ester|cassinolide
(12beta,22R)-12,22-diacetoxy-cholesta-1,4-dien-3-one
2alpha,3alpha-di-O-carbonyl-2alpha,3alpha-dihydroxytaraxer-14-en-28-oic acid
methyl 11alpha-hydroxy-3,7-dioxo-5alpha-lanosta-8,24(E)-dien-26-oate
(2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydrocyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid
2alpha-hydroxy-3beta-methoxy-6-oxo-13alpha,14beta,17alpha-lanosta-7,24-dien-21,16beta-olide
3beta,6alpha-Diacetoxy-5alpha-cholesta-9(11),24-dien-23-on
Me ether-11-Hydroxy-3,21-dioxo-12-oleanen-28-oic acid|Propapyriogenin A1
3,4-secotirucalla-23-oxo-4(28),7,24-trien-21-al-3,21-dioic acid 21-methyl ester
3,5-dihidroxy-4-<<(1R*,2S*,5S*)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl>methyl>-2-(3-methylbutanoyl)-6,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one|3,5-dihidroxy-4-{[(1R*,2S*,5S*)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl]methyl}-2-(3-methylbutanoyl)-6,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one|3,5-dihydroxy-4-{[(1R,2S,5S)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl]methyl}-2-(3-methylbutanoyl)-6,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one
11alpha-Hydroxy-3,7-dioxo-5alpha-lanosta-8,24-diene-26-oic acid methyl ester
AIDS-113410
Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2]. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2].
[3-carboxy-2-[(5Z,8E,13E)-11,12,15-trihydroxyicosa-5,8,13-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[7-[3-hydroxy-2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoyloxy]propyl]-trimethylazanium
[3-carboxy-2-[7-[5-hydroxy-2-[(E)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]heptanoyloxy]propyl]-trimethylazanium
2,3-Dihydroxypropyl (2-hydroxy-3-octadecoxypropyl) hydrogen phosphate
[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-hydroxypropyl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-hydroxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
(2r)-2-[(1r,2r,3as,3bs,7r,9ar,11ar)-2,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4-oxo-1h,2h,3h,3bh,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid
7-(acetyloxy)-9a,11a-dimethyl-1-(6-methyl-4-oxohept-2-en-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-5-yl acetate
methyl 2-methyl-2-[(1r,5s,6r,9r,10r,13s,14r,16r)-5,9,10-trimethyl-13-[(2e)-6-methyl-4-oxohepta-2,5-dien-2-yl]-3-oxo-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadecan-6-yl]propanoate
(2z,6r)-6-[(2r,4as,4br,7s,8s,9ar)-8-(2-carboxyethyl)-9a-methoxy-4a,8-dimethyl-1-methylidene-7-(prop-1-en-2-yl)-3,4,4b,5,6,7-hexahydro-2h-fluoren-2-yl]-2-methylhept-2-enoic acid
16α, 25-dihydroxydehydroeburicoic acid
{"Ingredient_id": "HBIN001797","Ingredient_name": "16\u03b1, 25-dihydroxydehydroeburicoic acid","Alias": "NA","Ingredient_formula": "C31H46O5","Ingredient_Smile": "CC1(C2CC=C3C(=CCC4(C3(CC(C4C(CCC(=C)C(C)(C)O)C(=O)O)O)C)C)C2(CCC1=O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41113","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6α-Hydroxypolyporenic acid C
{"Ingredient_id": "HBIN012207","Ingredient_name": "6\u03b1-Hydroxypolyporenic acid C","Alias": "NA","Ingredient_formula": "C31H46O5","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CC(C4C3(CCC(=O)C4(C)C)C)O)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35871","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}